Ira Shah1. 1. Pediatric HIV Clinic, B. J. Wadia Hospital for Children, 240 D. Walkeshwar Road, Malabar Hill, Parel, Mumbai 400006, India. irashah@pediatriconcall.com
Abstract
OBJECTIVE: To determine incidence of Immune Reconstitutional Syndrome (IRIS) in HIV infected children and also to determine risk factors associated with it. METHODS: Thirty-seven HIV infected children who were started on Antiretroviral therapy (ART) in past 2 years were included in the study. Statistical Analysis was done using Chi Square test. RESULTS: Seven patients (18.9%) had IRIS at a mean interval of 1.7 ± 0.8 months. Two patients (28.6%) had tuberculosis (TB), 2 patient (28.6%) had herpes zoster and 1 patient (14.3%) each had pneumonia, toxoplasmosis and esophageal candidiasis. There was no significant difference as per age (p = 0.8), WHO Stage of disease (p = 0.93), Sex (0.45), type of antiretroviral regime (p = 0.38) and severity of immune suppression (0.98). It was found that patients with opportunistic infections (OIs) before treatment would have increased incidence of IRIS (p = 0.05). The mean OIs/year prior to treatment in patients with IRIS was 2.6 ± 1.4 vs. 1.7 ± 1.2. CONCLUSIONS: Incidence of IRIS in HIV infected children in Mumbai is 18.9%. Patients with OIs before treatment with ART have an increased incidence of IRIS. Clinical stage of disease or degree of immune suppression prior to treatment had no effect on incidence of IRIS.
OBJECTIVE: To determine incidence of Immune Reconstitutional Syndrome (IRIS) in HIV infectedchildren and also to determine risk factors associated with it. METHODS: Thirty-seven HIV infectedchildren who were started on Antiretroviral therapy (ART) in past 2 years were included in the study. Statistical Analysis was done using Chi Square test. RESULTS: Seven patients (18.9%) had IRIS at a mean interval of 1.7 ± 0.8 months. Two patients (28.6%) had tuberculosis (TB), 2 patient (28.6%) had herpes zoster and 1 patient (14.3%) each had pneumonia, toxoplasmosis and esophageal candidiasis. There was no significant difference as per age (p = 0.8), WHO Stage of disease (p = 0.93), Sex (0.45), type of antiretroviral regime (p = 0.38) and severity of immune suppression (0.98). It was found that patients with opportunistic infections (OIs) before treatment would have increased incidence of IRIS (p = 0.05). The mean OIs/year prior to treatment in patients with IRIS was 2.6 ± 1.4 vs. 1.7 ± 1.2. CONCLUSIONS: Incidence of IRIS in HIV infectedchildren in Mumbai is 18.9%. Patients with OIs before treatment with ART have an increased incidence of IRIS. Clinical stage of disease or degree of immune suppression prior to treatment had no effect on incidence of IRIS.
Authors: M A French; N Lenzo; M John; S A Mallal; E J McKinnon; I R James; P Price; J P Flexman; M L Tay-Kearney Journal: HIV Med Date: 2000-03 Impact factor: 3.180
Authors: Samuel A Shelburne; Fehmida Visnegarwala; Jorge Darcourt; Edward A Graviss; Thomas P Giordano; A Clinton White; Richard J Hamill Journal: AIDS Date: 2005-03-04 Impact factor: 4.177
Authors: Salvador Resino; Elena Seoane; Alicia Pérez; Ezequiel Ruiz-Mateos; Manuel Leal; Maria A Muñoz-Fernández Journal: BMC Infect Dis Date: 2006-07-13 Impact factor: 3.090
Authors: A Bamford; A Turkova; H Lyall; C Foster; N Klein; D Bastiaans; D Burger; S Bernadi; K Butler; E Chiappini; P Clayden; M Della Negra; V Giacomet; C Giaquinto; D Gibb; L Galli; M Hainaut; M Koros; L Marques; E Nastouli; T Niehues; A Noguera-Julian; P Rojo; C Rudin; H J Scherpbier; G Tudor-Williams; S B Welch Journal: HIV Med Date: 2015-02-03 Impact factor: 3.180
Authors: George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim Journal: Pediatr Infect Dis J Date: 2013-11 Impact factor: 2.129